Skip to content

WE SHIP OUR PRODUCTS WORLDWIDE. FREE DOMESTIC SHIPPING ON ORDERS OVER $175.

 
Home / Products / Joint Support Nutrients (formerly AR-Encap®)
Quick view
Quick view
$56.00
View full details Link chevron
DESCRIPTION
INGREDIENTS
DOSAGE
SIZE

Comprehensive joint support – with Meriva®

Glucosamine provides proven joint support* with Meriva® curcumin phytosome, and Boswellia which helps support the body's normal inflammatory response*. Helps maintain already normal joint mobility and relief from occasional soreness and stiffness.

Comprehensive joint support – with Meriva® Curcumin Phytosome*

Glucosamine provides proven joint support*
Meriva® curcumin phytosome and Boswellia help support the body's normal inflammatory response*
Helps maintain already normal joint mobility*

A comprehensive joint support formula that goes beyond simple glucosamine supplementation.* This formula supplies the recommended daily dose of glucosamine in combination with joint-supporting nutrients and botanicals.*

Methyl sulfonyl methane (MSM), also known as dimethyl sulfone (DMSO2) and methyl sulfone, is an organic sulfur-containing compound that occurs naturally in a variety of fruits, vegetables, grains, and animals, including humans.

Curcumin, the principal polyphenol in the Indian spice turmeric, exerts potent antioxidant effects.* Curcumin Phytosome is a compound containing curcumin and pure phosphatidylcholine. This compound has demonstrated significantly better absorption than ordinary curcumin and helps support the body's normal inflammatory response.*

Glucosamine can provide significant joint support, as evidenced by numerous clinical studies.

Bromelain promotes healing after trauma*

In addition to glucosamine sulfate, MSM, and curcumin, Joint Support Nutrients contains the botanical Boswellia. Boswellia appears to inhibit the activity of lipoxygenase enzymes, thus promoting the body's normal inflammatory response.* In a double-blind study, an herb/nutrient formula, whose main ingredients were Boswellia and curcumin, resulted in significant support of already normal joint mobility in the active treatment group compared to placebo.